Ahold Delhaize’s CFO to leave company
Ahold Delhaize today announced that chief financial officer Natalie Knight is leaving the company to pursue another career opportunity. A search for a successor has begun, the company said.
Chain Drug Review
Ozanian named chief experience officer at JUICE Pharma
Industry veteran Chris Ozanian has been appointed chief experience officer at creative and marketing communications agency JUICE Pharma Worldwide.
CVS Health in talks to buy Oak Street Health
CVS Health is looking at the acquisition of primary care center operator Oak Street Health, Bloomberg News reported on Monday citing people familiar with the topic. No final decision has been made and discussions could fall through, the report added.
Rite Aid joins KUBRA retail cash payments network
KUBRA has announced the addition of Rite Aid to its cash payment network of retailers, giving cash-paying customers thousands of new retail locations where they can pay their bills.
ProBioGen collaborates with Boehringer Ingelheim
ProBioGen announced on Tuesday a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen’s DirectedLuck transposase technology.
FDA grants accelerated approval for Alzheimer’s Disease Treatment
The U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the accelerated approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease.
GNC launches limited time Total Lean Lean Shake 25 Twin Pack
PITTSBURGH – Science-backed ingredients and powerful flavors are synonymous with GNC Total Lean. The brand – which includes products across categories including meal replacements, weight management supplements and savory snacks – is built with science-backed, results-driven formulations.
Aurobindo receives FDA approval for lacosamide tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application lacosamide tablets USP, 50mg, 100mg, 150mg, and 200mg.
Aurobindo gets FDA approval for dimethyl fumarate delayed-release capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Dimethyl Fumarate Delayed-Release Capsules, 120mg and 240mg.
Bausch + Lomb unveils enhanced PreserVision AREDS 2 Formula mini soft gels with OCUSorb
Bausch + Lomb Corp. announced the U.S. introduction of PreserVision AREDS 2 Formula mini soft gels with OCUSorb. This product is the only AREDS 2 eye vitamin with the OCUSorb formulation.
Heyward Donigan departing Rite Aid
Rite Aid Corp. announced Monday that its board of directors has appointed Elizabeth (“Busy”) Burr, a member of the company’s board, as interim CEO, effective immediately. Burr’s appointment follows Heyward Donigan’s departure from the company as president and CEO, and as a member of the board.
2023 Retail Forecast
Top chain drug and distribution executives give their outlook for 2023 on the following pages, detailing the challenges and opportunities that lie ahead for the industry.
PQA expands the Social Determinants of Health Resource Guide
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) has expanded the PQA Social Determinants of Health (SDOH) Resource Guide. The second edition of this guide profiles 32 SDOH services, including 12 new services and updates to nine initiatives from the first edition.
Mars celebrates women with M&M’S limited-edition packs
This month, M&M’S, proudly part of Mars, will release its first-ever packs spotlighting dynamic female M&M’S characters. The all-female packs celebrate women everywhere who are flipping the status quo.
Alex Gourlay appointed as executive chair of Holland & Barrett
Former Walgreens executive Alex Gourlay has been appointed executive chair of Holland & Barrett, a leading wellness business and one of the largest in Europe.
Hy-Vee offering more options for Medicare Part D beneficiaries
Hy-Vee, Inc. announced that Medicare Part D beneficiaries are now able to access reduced-cost monthly insulin supplies and free Shingrix vaccines at all Hy-Vee Pharmacy locations, as outlined in the recent Inflation Reduction Act, which went into effect Jan. 1, 2023.